OLOPA Tablet (Olopatadine Hydrochloride)

Adult dose

For typical adults, 5 mg of Olopatadine Hydrochloride should be taken orally twice a day (in the morning and before bed). The dosage may be adjusted according to age and symptoms.

Child dose

Children aged 10 years and over should take 5 mg of Olopatadine Hydrochloride orally twice a day (in the morning and before bed).

This medicine contains lactose, so individuals with genetic disorders that affect lactose digestion should not take it. People allergic or hypersensitive to soybean oil, soy, and peanuts should also avoid this medication. Those with impaired kidney function, the elderly, or individuals with liver function issues should be especially cautious when using this medicine. Additionally, this medicine contains the dye Tartrazine (Yellow No. 5), so those allergic to this component should be careful as well. During use, side effects such as drowsiness, fatigue, dry mouth, and abdominal pain may occur. Rarely, severe liver impairment or jaundice may develop; consult a doctor immediately if symptoms appear. Care should be taken when driving or operating hazardous machinery due to the potential for drowsiness to cause accidents. Pregnant women or those who may become pregnant should weigh the benefits and risks carefully before taking this medication, and breastfeeding women should avoid using it or stop breastfeeding, if possible. Caution is needed when administering this medicine to children, especially those under 10 years of age, as safety has not been sufficiently established. This medicine may interfere with allergy tests, so it is advisable not to take it before undergoing testing. Keep the medicine out of the reach of children and avoid transferring it to another container.

Serious side effects

• Fulminant hepatitis
• liver dysfunction
• jaundice
• shortness of breath
• hypersensitivity.

Mild side effects

Drowsiness, lethargy, dry mouth, abdominal pain, skin rash including erythema, swelling (facial, extremities, etc.), pruritus, headache, heaviness in the head, dizziness, numbness, decreased concentration, involuntary movements (facial, extremities, etc.), abdominal discomfort, diarrhea, nausea, constipation, stomatitis, cheilitis, sore throat, heartburn, increased appetite, vomiting, leukocytosis, leukopenia, eosinophilia, lymphopenia, hematuria, increased BUN, positive urine protein, increased serum creatinine.

This medicine must be stored in a tightly sealed container to protect it from air and moisture, and it is best kept at room temperature between 1°C and 30°C. By storing it this way, the efficacy of the medicine is well maintained and degradation is prevented.

Appearance

Pale yellowish-red round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle